3-rx.comCustomer Support
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics

\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>

Join our Mailing List


You are here : 3-RX.com > Home > Asthma -

Steroid puff best for kids with persistent asthma

AsthmaFeb 13, 06

In a study of children with mild-to-moderate persistent asthma, treatment with fluticasone (Flovent), an inhaled steroid, was consistently more effective than treatment with montelukast (Singulair), an oral anti-asthma drug from the leukotriene receptor antagonist (LTRA) class of agents, investigators report.

In the 8-week crossover study of 127 asthmatic children 6 to 17 years of age, fluticasone was associated with significantly more asthma-free days, better asthma control, and decreased need for albuterol “rescue” puffs, compared with montelukast, the investigators report.

Fluticasone also produced significantly greater improvements in various measures of lung function, Dr. Robert S. Zeiger, from the University of California, San Diego, and associates report in the Journal of Allergy and Clinical Immunology.

These findings, the authors conclude, support recommendations for inhaled corticosteroids as the preferred first-line controller therapy for mild-to-moderate persistent childhood asthma. Up until now, there has been relatively little information available about the use of LTRAs in children with asthma, they point out.

Given these results, does montelukast have a place in treatment of pediatric asthma patients? “Patients who had a high degree of allergic airway inflammation and indicators consistent with allergic airway inflammation should be directed to an inhaled steroid,” answered co-author Dr. Stanley J. Szefler, from the National Jewish Medical & Research Center in Denver, Colorado. “Others could receive a trial of either medication.”

SOURCE: Journal of Allergy and Clinical Immunology January 2006.

Print Version
comments powered by Disqus

  Poorly controlled asthma costly
  Protein associated with allergic response causes airway changes in asthma patients
  Landmark Study Shows Suboptimal Asthma Care
  Acetaminophen use in adolescents linked to doubled risk of asthma
  Asthma and Eczema Sufferers Have a Lower Risk of Developing a Cancer
  ‘TIMely’ intervention for asthma
  Eliminating the source of asthma-causing immune molecules
  Does breastfeeding protect against asthma?
  Sleep apnea as common as asthma in German kids
  Parent mentors can improve the asthmatic care of minority children, UT Southwestern researchers find
  Sweet! Sugared Polymer a New Weapon Against Allergies and Asthma
  Asthma: Epidemiology, etiology and risk factors


Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site